CABAZITAXEL-TEVA cabazitaxel 60 mg/6 mL concentrated injection vial

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

cabazitaxel ethyl acetate solvate, Quantity: 66.32 mg (Equivalent: cabazitaxel, Qty 60 mg)

Dostopno od:

Teva Pharma Australia Pty Ltd

Farmacevtska oblika:

Injection, concentrated

Sestava:

Excipient Ingredients: macrogol 400; citric acid; polysorbate 80; ethanol absolute

Pot uporabe:

Intravenous Infusion

Enote v paketu:

1 vial

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Cabazitaxel-Teva in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Povzetek izdelek:

Visual Identification: Cabazitaxel-Teva is presented as a 60 mg/6 mL sterile, clear, oily, light yellow solution in a single use vial, practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Status dovoljenje:

Registered

Datum dovoljenje:

2020-09-16